Utah Medical Products, Inc. Form 8-K August 31, 2005

0001096906-05-000510.txt : 20050901 0001096906-05-000510.hdr.sgml : 20050901 20050901164222 ACCESSION NUMBER: 0001096906-05-000510 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050831 ITEM INFORMATION: Other Events FILED AS OF DATE: 20050901 DATE AS OF CHANGE: 20050901 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UTAH MEDICAL PRODUCTS INC CENTRAL INDEX KEY: 0000706698 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 870342734 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12575 FILM NUMBER: 051065137 BUSINESS ADDRESS: STREET 1: 7043 S 300 WEST CITY: MIDVALE STATE: UT ZIP: 84047 BUSINESS PHONE: 8015661200 8-K 1 utahmedical8k083105.htm UTAH MEDICAL PRODUCTS, INC. FORM 8-K AUGUST 31, 2005 Utah Medical Products, Inc. Form 8-K August 31, 2005

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (date of earliest event reported): August 31, 2005

Commission File No. 0-11178

UTAH MEDICAL PRODUCTS, INC.

(Exact name of Registrant as specified in its charter)

UTAH	87-0342734
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

7043 South 300 West

Midvale, Utah 84047

Address of principal executive offices

Registrant's telephone number: (801) 566-1200

ITEM 8.01 OTHER EVENTS

On September 1, 2005, Utah Medical Products, Inc. issued a press release announcing that its FDA trial has been rescheduled. A copy of the press release is attached hereto as Exhibit 99.1

SIGNATURES

Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	UTAH MEDICAL PRODUCTS, INC.
	REGISTRANT


Date: 9/1/05	By:	/s/ Kevin L. Cornwell
		Kevin L. Cornwell
		CEO

EXHIBIT INDEX

Index Number	Description

99.1	Press release issued September 1, 2005: FDA Trail Rescheduled

EX-99.1 2 utahmedical8k083105ex99-1.htm EXHIBIT 99.1 Exhibit 99.1

EXHIBIT 99.1

Salt Lake City, Utah - On August 31, 2005, the U.S. District Court in Salt Lake City expeditiously rescheduled the beginning date for the trial of the lawsuit filed in August 2004 on behalf of the U.S. Food and Drug Administration (FDA) alleging Quality System Regulation (QSR) violations by Utah Medical Products, Inc. (Nasdaq: UTMD).

The trial will either begin on September 26, 2005 or November 9, 2005. The alternative date of November 9 will occur if FDA counsel is unable to attend on September 26 due to a scheduling conflict with another trial. According to FDA counsel, UTMD should know by September 13 if the latter trial date is required.

UTMD looks forward to finally resolving the matter, and remains confident that the Company’s quality system complies with all applicable regulations.

Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures, assembles and markets a broad range of well-established, safe and effective, disposable and reusable specialty medical devices.